$NBIS personal view:
Q3 revenue came in at $981 million, up 571% year over year. AI cloud adjusted EBITDA margin reached 53%.
The company cut its 2026 revenue outlook to the low end of the previous range due to third-party data center delays. Some capacity has been pushed into 2027, but management said the contracts are still in place.
Management continues to guide for significant scale in 2027, with revenue expected to reach $12–13 billion.
The main risk right now is execution and delivery timing. If they can bring the delayed capacity online, operating leverage should improve and support a valuation reset.
I still see $NBIS as a high-conviction name. If execution holds, I think the stock can retest $195 by the time they report Q4 results.
Like❤️ and follow🔂 me for more news and information.
🚨 Nvidia board rules out Jensen return
Despite the petition (180k+ signatures), Elon Musk, and Trump saying he “would not mind,” the board is not considering bringing Jensen back as CEO.
Focus is on the national security investigation.
$NVDA down again today ahead of tomorrow’s earnings — first report under interim CEO Colette Kress.
AI trade is getting tested hard this week.
Like❤️ and follow for more stock analysis.
$SPCX: First orbital Starship catch.
Ship completed 14 orbits / 22.5 hours, deployed 26 Starlink V3 satellites, and was caught by the tower
Booster recovery aborted
Stock ~$139, market cap ~$1.9T
Analyst average target ~$250–$256 (+80% upside), with high-end targets at $800
Progress is real. The next key metric is dual recovery and faster turnaround.
Like❤️ and follow for more stock analysis.
If you're under 48,I’m only going to say this ONCE I don't give a FUCK if you have $1000, $10,000 or even $100,000 in your portfolio, Biotech stocks are going to make people generational WEALTH this year.
Here are 5 stocks I believe can 10x:
1) $NBIS
$NVDA reports earnings tomorrow — the first print without Jensen Huang.
Huang resigned last week amid personal controversies; interim CEO is Colette Kress
Stock has lost roughly $1.9T in market value since early October
Reports over the weekend suggest he is discussing a possible comeback
Expectations are high: analysts look for ~90% earnings growth on ~$109B revenue
Leadership uncertainty is the main overhang. A strong beat and confident outlook could stabilize sentiment; any guidance cut or weak tone on AI demand would likely extend the selloff.
This week also brings the Anthropic IPO, another test for the AI trade.
Remember to like❤️ and follow for more stock analysis.
A new week.
The market is still in a panic, and my position remains unchanged.
Current holdings: 125,000 shares of $IREN
Average cost: $24.33
Current loss: Approximately 28%
I haven't sold, and I don't plan to sell.
This is my actual holding.
Follow me; I will continue to disclose position changes and key developments this week.
AI infrastructure stocks have a bigger problem than most people think: the cost of capital.
Higher rates mean higher funding costs, and these companies are spending tens of billions building AI capacity.
Look at the numbers:
$CRWV — $47.5B debt | $4.1B cash | $37–39B FY26 capex
$NBIS — $40–45B expected FY27 capex
$IREN — $15B remaining FY27 capex
$SPCX — ~$89.9B cash + short-term securities
$ASTS — heavy satellite spending, funding and cash runway matter
The key point is simple:
Even if rates fall and lower the cost of capital, it won’t save companies with weak execution, project delays, or tight cash flow.
Capital efficiency matters more than ever.
If rates start coming down, which company benefits the most?
$CRWV, $NBIS, $IREN or $ASTS?
Drop your pick below👇
Remember to like❤️ and follow for more stock analysis.
🚨 $SPCX SpaceX Starship Flight 15 Successfully Launches!
The S42 upper stage successfully reaches orbit, while the B22 Super Heavy booster encounters an issue during its return. The tower catch attempt is aborted, and the booster splashes down in the ocean instead.
( Chinese and English version )
If you find this content useful, please like, follow, and share.
$600 billion wiped off $NVDA
in one day. Here’s exactly why I’m buying, not selling.
Here are 5 AI stocks I’m positioning in RIGHT NOW to 10x my portfolio.
1. $NVDA
🚨 $NBIS BEAT THE NUMBERS. SO WHY IS THE MARKET STILL DOUBTING IT?
Q3 revenue hit $980M, up from just $50M in Q1 2025.
Look at what's coming:
🔹 2027 revenue outlook: $12–13B
🔹 Pre-tax breakeven targeted by end of 2027.
🔹 75–85% of 2027 CapEx expected to be covered by customer prepayments and contract-backed financing.
Rapid growth, a path to profitability, and less reliance on shareholder dilution.
Maybe the problem isn't $NBIS. Maybe the market isn't looking far enough ahead.
#NBIS #AI
If this was helpful, please like and follow for more.